BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22997346)

  • 1. Endothelin-1 and endothelin receptor gene variants and their association with negative outcomes following aneurysmal subarachnoid hemorrhage.
    Gallek M; Alexander S; Crago E; Sherwood P; Horowitz M; Poloyac S; Conley Y
    Biol Res Nurs; 2013 Oct; 15(4):390-7. PubMed ID: 22997346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
    Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
    J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.
    Heinsberg LW; Arockiaraj AI; Crago EA; Ren D; Shaffer JR; Sherwood PR; Sereika SM; Weeks DE; Conley YP
    Neurocrit Care; 2020 Apr; 32(2):550-563. PubMed ID: 31346934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of haptoglobin genotype as a risk of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Ateia AM; Elbassiouny A; El-Nabi SH; Fahmy NA; Ibrahim MH; El-Garawani I; Geba KM; Khalaf M
    Clin Neurol Neurosurg; 2020 Dec; 199():106296. PubMed ID: 33069930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia.
    Thampatty BP; Sherwood PR; Gallek MJ; Crago EA; Ren D; Hricik AJ; Kuo CW; Klamerus MM; Alexander SA; Bender CM; Hoffman LA; Horowitz MB; Kassam AB; Poloyac SM
    Neurocrit Care; 2011 Aug; 15(1):19-27. PubMed ID: 21286855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage.
    Leclerc JL; Blackburn S; Neal D; Mendez NV; Wharton JA; Waters MF; Doré S
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1155-60. PubMed ID: 25583472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 gene polymorphisms influence cerebrospinal fluid endothelin-1 levels following aneurysmal subarachnoid hemorrhage.
    Gallek MJ; Alexander SA; Crago E; Sherwood PR; Klamerus M; Horowitz MB; Poloyac SM; Conley Y
    Biol Res Nurs; 2015 Mar; 17(2):185-90. PubMed ID: 24852947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ryanodine Receptor 1 Polymorphism Is Not Associated with Aneurysmal Subarachnoid Hemorrhage or its Clinical Sequelae.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    World Neurosurg; 2017 Apr; 100():190-194. PubMed ID: 28087430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Genetic Polymorphisms and Susceptibilities to Complications after Aneurysmal Subarachnoid Hemorrhage.
    Medina-Suárez J; Rodríguez-Esparragón F; Sosa-Pérez C; Cazorla-Rivero S; Torres-Mata LB; Jiménez-O'Shanahan A; Clavo B; Morera-Molina J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low total cholesterol and high density lipoprotein are independent predictors of poor outcomes following aneurysmal subarachnoid hemorrhage: A preliminary report.
    Li B; McIntyre M; Gandhi C; Halabi M; Long A; Van Hoof A; Afridi A; Schmidt M; Cole C; Santarelli J; Al-Mufti F; Bowers C
    Clin Neurol Neurosurg; 2020 Oct; 197():106062. PubMed ID: 32688095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-function polymorphisms of cystathionine β-synthase and delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.
    Grobelny BT; Ducruet AF; DeRosa PA; Kotchetkov IS; Zacharia BE; Hickman ZL; Fernandez L; Narula R; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
    J Neurosurg; 2011 Jul; 115(1):101-7. PubMed ID: 21417705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variability in the Iron Homeostasis Pathway and Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.
    Heinsberg LW; Alexander SA; Crago EA; Minster RL; Poloyac SM; Weeks DE; Conley YP
    Neurocrit Care; 2020 Dec; 33(3):749-758. PubMed ID: 32246437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in genes of the endothelin system and cerebral small-vessel disease.
    Gormley K; Bevan S; Hassan A; Markus HS
    Stroke; 2005 Aug; 36(8):1656-60. PubMed ID: 16002759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of High-Mobility Group Box 1 Polymorphism on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    World Neurosurg; 2017 May; 101():325-330. PubMed ID: 28189859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin polymorphisms as a risk factor for cerebral aneurysm rebleeding following aneurysmal subarachnoid hemorrhage.
    Foreman PM; Starke RM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M; Griessenauer CJ
    Clin Neurol Neurosurg; 2017 Jun; 157():65-69. PubMed ID: 28412541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cystathionine beta-synthase polymorphisms and aneurysmal subarachnoid hemorrhage.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    J Neurosurg; 2018 Jun; 128(6):1771-1777. PubMed ID: 28777022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of associations of genetic polymorphisms with cerebral vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Solodovnikova Y; Ivaniuk A; Marusich T; Son A
    Acta Neurol Belg; 2022 Dec; 122(6):1547-1556. PubMed ID: 34725794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of renin-angiotensin system genetic polymorphisms and clinical course after aneurysmal subarachnoid hemorrhage.
    Griessenauer CJ; Tubbs RS; Foreman PM; Chua MH; Vyas NA; Lipsky RH; Lin M; Iyer R; Haridas R; Walters BC; Chaudry S; Malieva A; Wilkins S; Harrigan MR; Fisher WS; Shoja MM
    J Neurosurg; 2017 May; 126(5):1585-1597. PubMed ID: 27285537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Nitric Oxide Synthase Polymorphism Is Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    World Neurosurg; 2017 May; 101():514-519. PubMed ID: 28254540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD; Vermeulen M; Murray GD; Pickard JD; Bell BA; Teasdale GM
    J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.